Insurance Denied Chemotherapy — Here's How to Fight Back
Your insurer denied chemotherapy coverage. This is one of the most common wrongful denials — and one of the most successfully appealed. Here's how to fight it.
Having chemotherapy denied by your insurance company is one of the most devastating experiences a cancer patient can face. But chemotherapy denial appeals have among the highest success rates of any insurance appeal — particularly when backed by NCCN guidelines and your oncologist's clinical letter. Here's how to fight back.
Why Insurers Deny Chemotherapy
The most common denial reasons for chemo coverage:
- "Not medically necessary" — claiming the specific regimen isn't clinically warranted
- "Experimental/investigational" — applied to combination regimens or immunotherapy combinations
- "Off-label use" — the drug is used outside its primary FDA-approved indication
- "Step therapy" — requiring you to try a different (often less effective) regimen first
- "Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization" — denying because the PA wasn't submitted before the first treatment
- "Out-of-network oncologist" — when the best oncologist for your cancer type is outside your network
Your Immediate Steps
1. Request expedited review. Cancer treatment denials qualify for expedited internal appeal and External Independent Review: Complete Guide" class="auto-link">external review. Under ACA regulations, expedited review must be completed within 72 hours. Call your insurer today and say: "I'm requesting an expedited internal appeal. Delay in receiving chemotherapy could seriously jeopardize my health."
2. Ask your oncologist to request a peer-to-peer review. Your oncologist speaking directly to the insurer's medical director often resolves chemo denials within 24 hours, without formal appeal. This should be your first call.
3. Have your oncologist prepare a medical necessity letter. The letter should include:
- Your specific cancer type, stage, and biomarkers (e.g., HER2+, KRAS mutation)
- The specific chemotherapy regimen and why it's indicated
- Reference to NCCN Category 1 or 2A guidelines supporting the regimen
- Clinical trial data or peer-reviewed literature if applicable
- Statement of urgency — treatment delay and clinical risk
The NCCN Guidelines: Your Strongest Evidence
The National Comprehensive Cancer Network (NCCN) publishes evidence-based clinical guidelines for every cancer type. Insurers are required to follow these guidelines or provide clinical justification for deviating from them.
For your appeal:
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
- Download the relevant NCCN guideline (nccn.org — free with registration)
- Identify the specific recommendation that supports your regimen (e.g., "Category 1: regimen X for stage III HER2+ breast cancer")
- Reference the specific NCCN version and page in your appeal letter
Most chemotherapy denials fall apart when confronted with NCCN Category 1 evidence.
Fighting an "Off-Label" Denial
Many highly effective chemo drugs are used off-label — outside their primary FDA-approved indication. This is legal and common in oncology. Your insurer must cover off-label use of FDA-approved cancer drugs when:
- The use is supported by peer-reviewed clinical literature in recognized compendia (e.g., NCCN Drugs & Biologics Compendium, Micromedex, Clinical Pharmacology)
- Federal Medicare Part B coverage rules (which most commercial insurers mirror) recognize the off-label indication
In your appeal: provide the compendia citation supporting the off-label use, plus published clinical trials.
State Protections for Cancer Treatment
Many states have laws specifically protecting cancer patients:
- Step therapy reform: 30+ states prohibit requiring cancer patients to "fail first" on alternative regimens
- External review for oncology: Most states require expedited external review for cancer treatment denials
- Continuity of care: Some states require insurers to maintain treatment continuity during network transitions
Check your state insurance department's website for cancer-specific protections.
If Chemo Is Urgent and You Can't Wait
- Ask your oncology center about treatment while appeal is pending — many cancer centers have financial advocacy teams that can arrange billing holds while an appeal is processed
- Manufacturer patient assistance programs — most major oncology drugs have free drug programs for patients in financial hardship
- American Cancer Society: 1-800-227-2345 — has patient service navigators who can help with insurance appeals
- CancerCare: cancercare.org — free professional oncology social worker guidance
Fight Back With ClaimBack
ClaimBack generates a chemotherapy appeal letter in 3 minutes — citing NCCN guidelines, FDA approval status, your specific denial reason, and the clinical evidence framework that wins chemo appeals.
Start your free chemotherapy appeal →
Related Reading
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides